Predictive Oncology (POAI) Price & Analysis

Compare

482 Followers

POAI Stock Chart & Stats

Day’s Range― - ―

52-Week Range$0.55 - $3.06

Previous CloseN/A

Volume663.11K

Average Volume (3M)156.83K

Market Cap

$9.85M

Enterprise Value$9.17M

Total Cash (Recent Filing)$506.08K

Total Debt (Recent Filing)$1.85M

Price to Earnings (P/E)―

Beta1.26

Next Earnings

Nov 06, 2025

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.22

Shares Outstanding10,892,657

10 Day Avg. Volume83,165

30 Day Avg. Volume156,828

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap0.93

Enterprise Value/Revenue8.57

Enterprise Value/Gross Profit26.26

Enterprise Value/Ebitda-1.16

Forecast

1Y Price Target

$1.00

Price Target Upside4.17% Upside

Rating ConsensusModerate Sell

Number of Analyst Covering1

Bulls Say, Bears Say

Bulls Say

TechnologyThe proprietary AI platform PEDAL has demonstrated the potential to identify biomarkers in cancer patients, making it an attractive licensing target.

Bears Say

Financial PerformancePredictive Oncology reported lower than expected revenue for 3Q24, indicating potential financial challenges.

Strategic UncertaintyThe company is undergoing a strategic review, which includes evaluating alternatives like a sale of the company or its assets, creating uncertainty.

Predictive Oncology News

Predictive Oncology, Every Cure announce strategic collaboration

Predictive Oncology (POAI) and Every Cure announced a strategic collaboration to identify and prioritize drugs for repurposing to...

5d ago

POAI

Predictive Oncology reports Q2 EPS (22c) vs. (53c) last year

Reports Q2 revenue $2,682 vs. $67,255 last year. “In addition to making noteworthy advancements in validating our proprietary...

26d ago

POAI

Predictive Oncology Sells Shares to Accredited Investor

The latest announcement is out from Predictive Oncology ( ($POAI) ). Predictive Oncology has issued and sold shares...

7d ago

POAI

Predictive Oncology Reports Significant Losses Amid Financial Challenges

Predictive Oncology Inc ( ($POAI) ) has released its Q2 earnings. Here is a breakdown of the information...

26d ago

POAI

Predictive Oncology Granted Nasdaq Compliance Extension

The latest announcement is out from Predictive Oncology ( ($POAI) ). Predictive Oncology Inc. faced potential delisting from...

2M ago

POAI

Predictive Oncology files to sell 1.92M shares of common stock for holders

22:24 EDT Predictive Oncology (POAI) files to sell 1.92M shares of common stock for holders Published first on...

2M ago

POAI

Predictive Oncology Sells Eagan Business to DeRoyal

Predictive Oncology ( ($POAI) ) has issued an update. On March 14, 2025, Predictive Oncology entered into an...

2M ago

POAI

Predictive Oncology issues letter to shareholders

Predictive Oncology (POAI) issued the following shareholder update: “The past several weeks have been particularly noteworthy and productive...

2M ago

POAI

Predictive Oncology Faces Nasdaq Non-Compliance Notice

Predictive Oncology ( ($POAI) ) has issued an announcement. On July 8, 2025, Predictive Oncology received a notification...

2M ago

POAI

Predictive Oncology Finalizes Stock Exchange Purchase Agreement

Predictive Oncology ( ($POAI) ) has provided an announcement. Predictive Oncology has entered into a Stock Exchange Purchase...

2M ago

POAI

Predictive Oncology enters standby equity purchase agreement with Yorkville

Predictive Oncology (POAI) has entered into a standby equity purchase agreement with YA II PN, LTD, an investment...

2M ago

POAI

Predictive Oncology develops functional 3D organoid models for Labcorp

Predictive Oncology (POAI) announced today the company has successfully developed 3D organoid models exclusively for Labcorp (LH), a...

3M ago

Predictive Oncology Faces Nasdaq Delisting Notice

The latest update is out from Predictive Oncology ( ($POAI) ). On June 9, 2025, Predictive Oncology Inc....

3M ago

POAI

Predictive Oncology says court denies Renovaro motion for expedited trial

Predictive Oncology (POAI) issued the following statement regarding its dispute with Renovaro (RENB): “Contrary to a press release...

4M ago

POAI

RENB

POAI FAQ

What was Predictive Oncology Inc’s price range in the past 12 months?

Predictive Oncology Inc lowest stock price was $0.55 and its highest was $3.06 in the past 12 months.

What is Predictive Oncology Inc’s market cap?

Predictive Oncology Inc’s market cap is $9.85M.

When is Predictive Oncology Inc’s upcoming earnings report date?

Predictive Oncology Inc’s upcoming earnings report date is Nov 06, 2025 which is in 58 days.

How were Predictive Oncology Inc’s earnings last quarter?

Predictive Oncology Inc released its earnings results on Aug 14, 2025. The company reported -$0.22 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.22.

Is Predictive Oncology Inc overvalued?

According to Wall Street analysts Predictive Oncology Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Predictive Oncology Inc pay dividends?

Predictive Oncology Inc does not currently pay dividends.

What is Predictive Oncology Inc’s EPS estimate?

Predictive Oncology Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Predictive Oncology Inc have?

Predictive Oncology Inc has 10,892,657 shares outstanding.

What happened to Predictive Oncology Inc’s price movement after its last earnings report?

Predictive Oncology Inc reported an EPS of -$0.22 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Predictive Oncology Inc?

Currently, no hedge funds are holding shares in POAI

Company Description

Predictive Oncology Inc

Predictive Oncology (POAI) is a biotechnology company focused on advancing personalized medicine through the development of innovative cancer treatment solutions. The company operates primarily in the healthcare sector, leveraging its proprietary artificial intelligence and machine learning technologies to analyze patient data and predict treatment outcomes. POAI's core products include a suite of predictive analytics tools that assist oncologists in selecting the most effective therapies for individual patients, thereby improving treatment efficacy and reducing costs associated with trial-and-error approaches in cancer care.

Predictive Oncology (POAI) Earnings & Revenues

Historic Earnings Reports

POAI Stock 12 Month Forecast

Average Price Target

$1.00

▲(4.17% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"26":"$26","-1":"-$1","5.75":"$5.75","12.5":"$12.5","19.25":"$19.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$1.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$1.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,5.75,12.5,19.25,26],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2021","6":"Nov<br/>2024","9":"Apr<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.76,0.7784615384615384,0.796923076923077,0.8153846153846154,0.8338461538461539,0.8523076923076923,0.8707692307692307,0.8892307692307693,0.9076923076923077,0.9261538461538461,0.9446153846153846,0.963076923076923,0.9815384615384615,{"y":1,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.76,0.7784615384615384,0.796923076923077,0.8153846153846154,0.8338461538461539,0.8523076923076923,0.8707692307692307,0.8892307692307693,0.9076923076923077,0.9261538461538461,0.9446153846153846,0.963076923076923,0.9815384615384615,{"y":1,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.76,0.7784615384615384,0.796923076923077,0.8153846153846154,0.8338461538461539,0.8523076923076923,0.8707692307692307,0.8892307692307693,0.9076923076923077,0.9261538461538461,0.9446153846153846,0.963076923076923,0.9815384615384615,{"y":1,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":22.4,"date":1612137600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.4,"date":1612137600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25,"date":1622505600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.8,"date":1635724800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.32,"date":1667260800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.11,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.69,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.82,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.82,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.48,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.17,"date":1746057600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.95,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.76,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >